Best Medical Oncologist in India: How to Choose a Cancer Physician

The medical oncologist leads the drug treatment of cancer and often coordinates the whole plan. This guide explains what they do, why testing guides treatment, how to judge one, and lists verified specialists across India.

Quick Answer
  1. 1

    A medical oncologist treats cancer with drugs — chemotherapy, targeted therapy, immunotherapy and hormone therapy — and often coordinates the overall plan.

  2. 2

    Modern drug therapy is guided by biomarker and molecular testing, so the right tests matter as much as the right doctor.

  3. 3

    Medical oncology in India is delivered at JCI- and NABH-accredited hospitals, generally far below Western prices.

  4. 4

    You can get a free written second opinion from an Indian medical oncologist before you travel.

  • Look for a DM or DrNB in Medical Oncology and a high volume of your cancer type.
  • Blood cancers are treated by a haemato-oncologist, a distinct field within medical oncology.
  • Verify any doctor on India's National Medical Commission register.

Explore best hospitals in detail below.

If a surgeon removes cancer and a radiation oncologist targets it with radiotherapy, the medical oncologist is the physician who treats it with drugs — and, for many patients, the one who coordinates the whole plan. For advanced cancer, blood cancer, or any cancer needing chemotherapy, they are the specialist you need.

This guide explains what a medical oncologist does, why modern treatment depends on testing, how to judge one, and the questions to ask — followed by verified specialists across India's leading hospitals.

What a Medical Oncologist Does

A medical oncologist manages the systemic treatment of cancer — therapy that works throughout the body rather than at one site:

  • Chemotherapy — drugs that kill or slow fast-dividing cancer cells.
  • Targeted therapy — drugs aimed at specific features of your cancer.
  • Immunotherapy — treatment that helps your immune system fight the cancer.
  • Hormone therapy — for cancers driven by hormones.

They also coordinate care across the team, manage advanced or recurrent disease, and handle the side effects of treatment. In many cancers, the medical oncologist is effectively the case's physician-in-charge.

When You Need a Medical Oncologist

You will usually see a medical oncologist if your cancer is advanced or has spread, if you need chemotherapy before or after surgery (neoadjuvant or adjuvant treatment), or if you have a blood cancer such as leukaemia, lymphoma or myeloma — treated by a haemato-oncologist, a distinct field within medical oncology. Even in surgery-led plans, a medical oncologist is often involved in deciding whether drug therapy is needed.

Precision Oncology: The Testing That Guides Treatment

Modern medical oncology is increasingly precision medicine — the drug is chosen for your cancer's specific features, not a one-size-fits-all protocol. That makes the right tests as important as the right doctor.

Depending on the cancer, these may include hormone-receptor tests (such as ER, PR and HER2 in breast cancer), genetic tests (such as BRCA and HRD), and molecular or biomarker tests (such as EGFR, PD-L1 or MSI) that show whether targeted therapy or immunotherapy is likely to help. A strong medical oncologist orders the right tests up front and explains what they mean for your options.

Ask what testing your plan is based on
Before starting drug treatment, ask which biomarker or molecular tests have been done and how they shape your options. A modern plan is built on your cancer's specific features — not a generic protocol.

How to Judge a Medical Oncologist

Every credential can be checked, and volume in your exact cancer matters more than general fame. Look for:

  • A super-specialty qualification — DM or DrNB in Medical Oncology (an MD plus fellowships, or international qualifications such as MRCP or ESMO/ECMO, are a plus).
  • A high volume of your specific cancer, and haemato-oncology expertise if you have a blood cancer.
  • A hospital that runs a multidisciplinary tumour board.
  • JCI or NABH accreditation, with molecular-testing capability.

You can confirm any doctor's registration on India's National Medical Commission register.

Ask whether your case goes to a tumour board
A medical oncologist should not decide drug treatment in isolation. At a serious centre, your case is reviewed by a multidisciplinary tumour board, so systemic therapy is sequenced correctly with surgery and radiotherapy.

Mistakes to Avoid

  • Starting chemotherapy without full testing — biomarker results can change the recommended drug.
  • Not distinguishing haemato-oncology — blood cancers need a specialist in that field.
  • Skipping the second opinion — a written review of your reports often refines the plan.
  • Choosing by fame alone — reputation is not the same as high volume in your exact cancer.

Questions to Ask a Medical Oncologist

  • What is my exact diagnosis, and which biomarker or molecular tests have been done?
  • What drug therapy do you recommend, and what is the goal?
  • Will my case go to a tumour board, and how is drug therapy sequenced with surgery or radiotherapy?
  • What are the side effects, and how will they be managed?
  • How many patients with my cancer do you treat each year?
  • What will treatment cost, in writing, including tests and supportive care?

Why International Patients Choose India for Medical Oncology

Drug therapy is where cost differences between India and the West are often largest, and India's leading centres pair it with modern testing and experienced specialists.

  • Cost — chemotherapy, targeted therapy and immunotherapy generally cost far less than in the US, UK or the Gulf (ask for an itemised estimate).
  • Testing — biomarker and molecular diagnostics at accredited labs.
  • Team care — multidisciplinary tumour boards at established centres.
  • Quality — JCI- and NABH-accredited hospitals; specialists trained in India and abroad.
  • Logistics — an e-Medical Visa on a hospital invitation letter; English-speaking teams; end-to-end coordination.

Your Journey as an International Patient

  1. Send reports — share your biopsy, scans and any biomarker reports for a free remote opinion.
  2. Get a plan — the right medical oncologist returns a written plan and an itemised cost.
  3. Visa — on a hospital invitation letter, you receive an e-Medical Visa.
  4. Treatment — you begin drug therapy at an accredited hospital, within a tumour-board plan.
  5. Follow-up home — cycles can sometimes continue at home under a shared-care plan, with teleconsultation.

Related Doctors

89 doctor
Dr. Vinod Raina
Dr. Vinod Raina

Chairman – Medical Oncology

Medical Oncologist

Breast cancerLung cancerGastrointestinal cancers (stomach, colorectal, oesophageal)
Gurgaon, IndiaFortis Memorial Research Institute

40+ years of experience

Dr. Vinod Raina is a distinguished figure in the field of Medical Oncology in India, with over 40 years of exemplary experience. He is currently associated with Fortis Memorial Research Institute in Gurugram, where he functions as the Chairman and Head of Medical Oncology and Hematology. His primary expertise lies in chemotherapy treatment and he was the first to perform high-dose chemotherapy in India. He also performed the first peripheral blood BMT in India — milestones that placed him at the frontier of oncology practice in the country during a period when these techniques were only available in the most advanced centres globally. Dr. Raina possesses specialised expertise in treating a wide spectrum of cancers including breast cancer, lung cancer, gastrointestinal cancer, urological cancer, gynaecological cancer, lymphoma, and myeloma. His contributions extend to performing approximately 400 BMTs, significantly enhancing treatment options for various cancers in India. Before joining Fortis, Dr. Raina was part of other renowned cancer hospitals such as the All India Institute of Medical Sciences (AIIMS), where during the last decade he performed the largest number of cancer-related transplants in India. He served as a Professor and Head of Medical Oncology at AIIMS, New Delhi, where he garnered immense respect for his knowledge and leadership. Throughout his career, Dr. Raina has worked across hospitals and medical institutes both in India and abroad. During his stint at AIIMS, he was the Principal Investigator of over 50 projects where he showcased his commitment to advancing oncology through rigorous scientific inquiry. He also co-founded the INDOX network, furthering collaborative research efforts in oncology. Moreover, he has been conducting the DM course for Medical Oncology for the last 15 years and has trained more than 70 residents and DM students at AIIMS, many of whom now occupy prominent positions in the field globally. He holds more than 200 publications in national and international medical journals worldwide.

Dr. Dipanjan Panda
Dr. Dipanjan Panda

Senior Consultant — Medical Oncology

Medical Oncologist

Blood cancers (leukaemia, lymphoma)Breast cancerLiver cancer (HCC)
New Delhi, IndiaIndraprastha Apollo Hospitals

15+ years of experience

Dr. Dipanjan Panda is one of the well-known Medical Oncologists in India, having 15+ years of expertise in treating bone and soft tissue cancers and gastrointestinal cancers. He is credited with starting the country's first anticancer departments and PDCC programme. Dr. Panda developed a medical oncology unit at Indraprastha Apollo Hospital in New Delhi, in association with the Institute of Liver and Biliary Sciences. He is currently working at Indraprastha Apollo Hospital in New Delhi as a Senior Consultant in Medical Oncology. Dr. Panda has written more than twenty peer-reviewed papers in national and international journals and has presented numerous talks at global oncology forums. His clinical interests span targeted therapy, immunotherapy, and the multidisciplinary management of complex gastrointestinal and hepato-pancreato-biliary cancers.

Dr. Ankur Bahl
Dr. Ankur Bahl

Principal Director — Medical Oncology

Medical Oncologist

Breast CancerLung CancerHead and Neck Cancer
Gurugram, IndiaFortis Memorial Research Institute

17+ years of experience

Dr. Ankur Bahl is the Principal Director of Medical Oncology at Fortis Memorial Research Institute in Gurugram, bringing over 17 years of specialised clinical experience in cancer treatment. A graduate of Maulana Azad Medical College, Delhi, where he completed both his MBBS and MD in Medicine, Dr. Bahl furthered his expertise by obtaining his DM in Medical Oncology from the prestigious All India Institute of Medical Sciences (AIIMS), New Delhi. He has also completed a specialized course on Adverse Drug Reactions, Drug Interactions, and Pharmacovigilance at the University of Oxford, UK, strengthening his evidence-based approach to cancer care. Dr. Bahl's clinical depth encompasses the full spectrum of medical oncology, including chemotherapy for solid tumours, neoadjuvant and adjuvant chemotherapy protocols, immunotherapy using immune checkpoint inhibitors, targeted molecular therapies, and hormonal treatment for breast cancer. He is recognised as the lead author of the largest real-world Indian dataset on targeted therapy with Cetuximab in head and neck cancer, acute myeloid leukaemia treatment, and Human Papillomavirus epidemiology in the Indian population—publications that have shaped understanding of cancer patterns and treatment efficacy in the region. His commitment to evidence-based oncology is evident through his active participation in tumour boards, master classes, and workshops across India and internationally. Dr. Bahl treats a substantial international patient cohort, welcoming patients from the Gulf Cooperation Council states, African nations, and South Asian countries seeking advanced oncological care. His fluency in English and Hindi enables seamless communication with diverse patient backgrounds. He provides comprehensive supportive and palliative care alongside curative treatments, ensuring patients receive holistic management throughout their cancer journey. Fortis Memorial Research Institute, where Dr. Bahl practises, is a leading tertiary-care cancer centre in Gurugram with state-of-the-art infrastructure, dedicated oncology wards, advanced diagnostic and treatment facilities, and a strong international patient support team. The hospital maintains accreditation standards and offers integrated care with specialist nurses, nutritionists, and counsellors. International patients benefit from streamlined admission processes, translation services, and coordination of follow-up care. Dr. Bahl's position as Principal Director ensures that patients receive leadership-level oversight of their treatment strategy, with access to the latest clinical protocols and innovations in cancer therapy.

Dr. Priya Tiwari
Dr. Priya Tiwari

Head of Department — Medical Oncology

Medical Oncologist

Breast cancerGynecological cancersGastrointestinal cancers
Gurugram, IndiaArtemis Hospital

20+ years of experience

Dr. Priya Tiwari is the Head of the Department of Medical Oncology at Artemis Hospital, Gurugram, and brings over 20 years of clinical expertise to cancer care. A distinguished graduate of the All India Institute of Medical Sciences (AIIMS), she holds an MD in Medicine and a DM in Medical Oncology, credentials that anchor her practice in rigorous evidence-based oncology. Her educational foundation at Jawaharlal Nehru Medical College, Banaras Hindu University (MBBS, 2006) reflects a career built on academic excellence—she secured the highest marks in her final exams and was recognized as the best outgoing female candidate at her institute. Dr. Tiwari's clinical depth spans a broad spectrum of malignancies, including breast cancer, gynecological cancers, gastrointestinal and hepatobiliary cancers, colorectal and lung cancers, brain tumors, and soft tissue sarcomas. She is particularly skilled in immunotherapy for solid tumors, hormonal therapy for hormone-responsive cancers, molecular targeted therapy based on biomarkers, and chemotherapy—both adjuvant and palliative. Her areas of interest also encompass cancer genetics and precision medicine, reflecting her commitment to personalized cancer treatment. She is an ESMO-certified Medical Oncologist and has pursued advanced training through preceptorships on kidney cancer in Taiwan (2015) and received travel grants to prestigious international forums including ESMO Asia in Singapore and oncology conferences in Sweden. Dr. Tiwari is highly experienced in managing international patients from across the Gulf region, Africa, and other geographies. She adopts a multidisciplinary approach to cancer management, addressing not only the disease but also the holistic concerns of her patients. Her practice reflects a deep commitment to palliative care and end-of-life support, ensuring that every patient receives compassionate, dignified treatment regardless of their cancer stage. She is fluent in English and Hindi, facilitating clear communication with patients from diverse backgrounds. Artemis Hospital, Gurugram is one of India's leading multispecialty healthcare institutions, accredited by NABH and equipped with state-of-the-art oncology facilities, advanced diagnostic imaging, and a dedicated cancer support infrastructure. The hospital's international patient services and comprehensive post-treatment follow-up protocols make it a preferred destination for cancer care. International patients can expect seamless coordination, transparent treatment planning, and access to cutting-edge therapies under Dr. Tiwari's expert oversight. For patients seeking specialized cancer treatment with a physician who balances clinical rigor with compassionate care, Dr. Tiwari's experience and hospital affiliation offer both clinical depth and logistical comfort. Her memberships in the American Society of Clinical Oncology (ASCO), European Society for Medical Oncology (ESMO), and the Immuno-oncology Society of India position her within the global oncology community, ensuring her patients benefit from the latest advances in cancer medicine.

Dr. Shefali Sardana
Dr. Shefali Sardana

Senior Consultant — Medical Oncology

Medical Oncologist

Gastric CancerColorectal CancerPancreatic Cancer
New Delhi, IndiaIndraprastha Apollo Hospital

20+ years of experience

Dr. Shefali Sardana is a Senior Consultant in Medical Oncology at Indraprastha Apollo Hospital in New Delhi with over 20 years of clinical expertise in cancer care. She holds an MBBS, MD in Medicine, and DNB in Medical Oncology, alongside recent fellowships in colorectal cancer management from Charité University Hospital in Berlin (2024) and kidney cancer treatment in Singapore (2019). Her qualifications and continuous engagement with international training programmes reflect her commitment to staying at the forefront of modern oncology. Dr. Sardana specialises in the comprehensive management of gastrointestinal, hepato-pancreato-biliary, and genitourinary cancers, with additional expertise in breast and gynaecological malignancies. She is highly skilled in delivering chemotherapy, immunotherapy, targeted therapy, hormone therapy, and CAR-T cell therapy. Throughout her career, she has administered and supervised over 40,000 cycles of systemic therapy and treated more than 15,000 cancer patients across early-stage, locally advanced, and metastatic disease settings. Her multidisciplinary approach to complex solid organ malignancies ensures individualised, evidence-based treatment plans. Dr. Sardana is an experienced clinical researcher and Principal Investigator in international oncology trials, with presentations at major global forums including ASCO-GI. She actively contributes to national cancer guidelines and medical textbooks, strengthening India's oncology knowledge base. She welcomes international patients from the Gulf region, Africa, and neighbouring countries, and is fluent in both English and Hindi, ensuring clear communication throughout the treatment journey. Her patient-centred philosophy combines advanced systemic therapy expertise with compassionate care. Indraprastha Apollo Hospital, where Dr. Sardana practises, is a world-renowned institution equipped with state-of-the-art oncology facilities, advanced diagnostic imaging, and robust supportive care services. The hospital's NABH and JCI accreditation, combined with dedicated international patient support, makes it an ideal destination for cancer care. Apollo Athenaa Women's Cancer Centre, affiliated with her practice, further specialises in breast and gynaecological malignancies. International patients choosing Dr. Sardana benefit from cutting-edge cancer treatment in a highly regulated healthcare environment, combined with the affordability and clinical depth that Indian oncology uniquely offers.

Frequently Asked Questions

What does a medical oncologist do?
A medical oncologist treats cancer with drugs — chemotherapy, targeted therapy, immunotherapy and hormone therapy — and often coordinates the overall plan. They manage advanced and recurrent disease, decide whether drug treatment is needed before or after surgery, and handle the side effects of treatment.
What is the difference between a medical, surgical and radiation oncologist?
A medical oncologist treats cancer with drugs. A surgical oncologist removes it with surgery. A radiation oncologist treats it with precisely targeted radiotherapy. Most patients need more than one, and for many cancers all three work together as a team.
What is precision oncology and biomarker testing?
Precision oncology means choosing drug treatment based on your cancer's specific features rather than a one-size-fits-all protocol. Tests such as hormone-receptor (ER, PR, HER2), genetic (BRCA, HRD) and molecular markers (EGFR, PD-L1, MSI) show whether targeted therapy or immunotherapy is likely to help. A strong medical oncologist orders the right tests up front.
How do I judge a medical oncologist's qualifications in India?
Confirm the super-specialty qualification (DM or DrNB in Medical Oncology), check the case volume in your specific cancer, ensure haemato-oncology expertise if you have a blood cancer, and check the hospital's NABH or JCI accreditation. Registration can be verified on India's National Medical Commission register.
How much does chemotherapy or cancer drug treatment cost in India?
Drug therapy in India generally costs far less than in the US, UK or the Gulf, and this is often where the difference is largest. The total depends on the drugs, the number of cycles and supportive care, so there is no fixed price — ask for an itemised written estimate before you travel.
Can I get a second opinion from a medical oncologist before travelling?
Yes. Your biopsy, scans and biomarker reports can be reviewed remotely by an Indian medical oncologist, who returns a written opinion and plan before you book any travel or visa. Through GAF this remote second opinion is free.

Patient Success Story

Iraqi Family's Journey: Baby Ibrahim's Life-Saving Heart Surgery in India

Get a Free Medical Opinion

An English-speaking patient coordinator will reach out within 24 hours.